Biographical Sketch
Robert Joseph Heyka, MD, is the Medical Director for the FMC/Cleveland Clinic East (Fairhill) Dialysis Center, the Medical Director for the FMC/Cleveland Clinic Solon Dialysis Center, the Director of Chronic Hemodialysis in the Department of Hypertension and Nephrology, and Chair of the Board of Directors for the FMC/Ohio Renal Care Group.
Dr. Heyka’s specialty interests include chronic and acute renal failure, lipid abnormalities in renal disease, dialysis, hypertension, renal bone disease, cardiovascular disease in kidney patients, and vascular access for dialysis. He is certified in Internal Medicine and Nephrology by the American Board of Internal Medicine.
He earned his medical degree from Wane State University School of Medicine in Detroit, MI. He completed an internship in Internal Medicine at William Beaumont Hospital in Royal Oak, Mich. He completed a residency at Bon Secours Hospital in Grosse Pointe Park, Mich. He was Boy Frame Lecturer in Bone and Mineral Metabolism in the Department of Endocrinology at Henry Ford Hospital in Detroit, as well as a Cleveland Clinic Fellow in Nephrology in the Department of Hypertension and Nephrology.
Dr. Heyka is a member of several professional societies, including the American College of Physicians; the American Society of Nephrology; the International Society of Nephrology; the National Kidney Foundation; American Heart Association, where he sits on the councils for high blood pressure research and kidney in cardiovascular disease; and the European Dialysis and Transplant Association.
Specialty Interests
cardiovascular disease in kidney patients, chronic and acute renal failure, Dialysis, Hypertension, lipid abnormalities in renal disease, renal bone disease, vascular access for dialysis, hypertension
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 9/10/2008, Dr.
Heyka has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Fiduciary Role. Dr. Heyka serves in a fiduciary capacity, such as an officer or director, for the following companies or other entities:
Ohio Renal Care Group
